A detailed history of Wealthfront Advisers LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Wealthfront Advisers LLC holds 138,970 shares of GILD stock, worth $13 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
138,970
Previous 109,544 26.86%
Holding current value
$13 Million
Previous $7.52 Million 55.0%
% of portfolio
0.04%
Previous 0.03%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$66.59 - $83.99 $1.96 Million - $2.47 Million
29,426 Added 26.86%
138,970 $11.6 Million
Q2 2024

Aug 14, 2024

SELL
$63.15 - $72.88 $3.64 Million - $4.2 Million
-57,583 Reduced 34.45%
109,544 $7.52 Million
Q1 2024

Apr 19, 2024

SELL
$71.58 - $87.29 $1.17 Million - $1.43 Million
-16,335 Reduced 8.9%
167,127 $12.2 Million
Q4 2023

Feb 09, 2024

BUY
$73.27 - $83.09 $49,237 - $55,836
672 Added 0.37%
183,462 $14.9 Million
Q3 2023

Nov 01, 2023

SELL
$73.94 - $80.67 $4.85 Million - $5.29 Million
-65,612 Reduced 26.41%
182,790 $13.7 Million
Q2 2023

Aug 07, 2023

BUY
$76.01 - $86.7 $598,882 - $683,109
7,879 Added 3.28%
248,402 $19.1 Million
Q1 2023

Apr 28, 2023

BUY
$77.31 - $88.08 $2.86 Million - $3.26 Million
37,018 Added 18.19%
240,523 $20 Million
Q4 2022

Feb 10, 2023

BUY
$62.32 - $89.47 $210,205 - $301,782
3,373 Added 1.69%
203,505 $17.5 Million
Q3 2022

Nov 14, 2022

BUY
$59.54 - $68.01 $3.51 Million - $4.01 Million
58,994 Added 41.8%
200,132 $12.3 Million
Q2 2022

Jul 20, 2022

BUY
$57.72 - $65.01 $3.18 Million - $3.58 Million
55,110 Added 64.06%
141,138 $8.72 Million
Q1 2022

May 16, 2022

SELL
$57.92 - $72.58 $1.33 Million - $1.67 Million
-22,947 Reduced 21.06%
86,028 $5.12 Million
Q4 2021

Jan 21, 2022

BUY
$64.88 - $73.64 $586,709 - $665,926
9,043 Added 9.05%
108,975 $7.91 Million
Q3 2021

Nov 15, 2021

BUY
$67.69 - $73.03 $1.72 Million - $1.86 Million
25,447 Added 34.16%
99,932 $6.98 Million
Q2 2021

Aug 16, 2021

BUY
$63.47 - $69.35 $776,872 - $848,843
12,240 Added 19.66%
74,485 $5.13 Million
Q1 2021

May 14, 2021

BUY
$60.0 - $68.46 $481,620 - $549,528
8,027 Added 14.81%
62,245 $4.02 Million
Q4 2020

Feb 16, 2021

SELL
$56.65 - $64.55 $496,254 - $565,458
-8,760 Reduced 13.91%
54,218 $3.16 Million
Q3 2020

Nov 16, 2020

SELL
$62.1 - $78.08 $1.53 Million - $1.92 Million
-24,561 Reduced 28.06%
62,978 $3.98 Million
Q2 2020

Aug 14, 2020

BUY
$72.34 - $84.0 $1.89 Million - $2.2 Million
26,186 Added 42.68%
87,539 $6.74 Million
Q1 2020

May 15, 2020

BUY
$62.63 - $80.22 $2.82 Million - $3.61 Million
44,973 Added 274.56%
61,353 $4.59 Million
Q4 2019

Jan 21, 2020

SELL
$61.62 - $67.78 $280,062 - $308,060
-4,545 Reduced 21.72%
16,380 $1.06 Million
Q3 2019

Oct 15, 2019

SELL
$62.51 - $69.0 $124,894 - $137,862
-1,998 Reduced 8.72%
20,925 $1.33 Million
Q2 2019

Aug 13, 2019

BUY
$61.87 - $69.38 $584,238 - $655,155
9,443 Added 70.05%
22,923 $1.55 Million
Q1 2019

May 13, 2019

SELL
$62.53 - $70.05 $725,598 - $812,860
-11,604 Reduced 46.26%
13,480 $876,000
Q4 2018

Feb 14, 2019

BUY
$60.54 - $79.0 $1.52 Million - $1.98 Million
25,084 New
25,084 $1.57 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $117B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Wealthfront Advisers LLC Portfolio

Follow Wealthfront Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthfront Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthfront Advisers LLC with notifications on news.